iShares Biotechnology ETF $IBB Stock Position Cut by Scotia Capital Inc.

Scotia Capital Inc. decreased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 18.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,402 shares of the financial services provider’s stock after selling 1,676 shares during the period. Scotia Capital Inc.’s holdings in iShares Biotechnology ETF were worth $936,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the stock. Berkshire Money Management Inc. bought a new position in shares of iShares Biotechnology ETF in the second quarter valued at approximately $28,000. Financial Gravity Companies Inc. bought a new stake in iShares Biotechnology ETF during the second quarter worth approximately $29,000. Harbor Asset Planning Inc. bought a new position in iShares Biotechnology ETF during the 2nd quarter valued at $31,000. Trust Co. of Toledo NA OH acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $32,000. Finally, Bronte Capital Management Pty Ltd. increased its position in shares of iShares Biotechnology ETF by 12.6% during the 2nd quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock valued at $37,000 after purchasing an additional 32,947 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $170.11 on Tuesday. The business has a fifty day simple moving average of $156.98 and a 200-day simple moving average of $140.87. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $174.40.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were given a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 annualized dividend and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.